10X GENOMICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.48 USD | +4.53% |
|
-0.40% | -50.89% |
| May. 02 | North American Morning Briefing : Stock Futures -2- | DJ |
| May. 01 | UBS Adjusts 10x Genomics Price Target to $30 From $52, Maintains Neutral Rating | MT |
Presentation Operator MessageOperator (Operator)Hello, good afternoon, and welcome to the 10x ...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
10x Genomics, Inc. is a life science technology company. The Company's integrated solutions include instruments, consumables and software for analyzing biological systems. Its Chromium platform includes its Chromium X Series, Chromium Connect and legacy Chromium Controller instruments, microfluidic chips and related consumables, which enables throughput analysis of individual biological components. Its Visium platform enables researchers to understand the spatial positions of biological analytes within tissues at high resolution. Its Xenium platform for in situ analysis is designed to give scientists the ability to not only locate and type cells in their tissue context. Its products include Chromium Single Cell Gene Expression, Chromium Single Cell Gene Expression Flex, Chromium Single Cell Immune Profiling, Chromium Single Cell assay for transposase accessible chromatin (ATAC), Chromium Single Cell Multiome ATAC + Gene Expression, Visium Spatial Gene Expression, and others.
Calendar
Trading Rating
Investor Rating
ESG Refinitiv
D+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
27.48
USD
Average target price
41.14
USD
Spread / Average Target
+49.72%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -50.89% | 3.29B | |
| -1.89% | 12.56B | |
| -9.59% | 7.68B | |
| -1.31% | 5.29B | |
| +21.82% | 5.18B | |
| +0.02% | 4.57B | |
| +6.42% | 2.6B | |
| -10.02% | 2.2B | |
| -8.29% | 1.79B | |
| +1.72% | 1.76B |
- Stock Market
- Equities
- TXG Stock
- News 10x Genomics, Inc.
- Transcript : 10x Genomics, Inc., Q4 2021 Earnings Call, Feb 16, 2022
